AvePoint (AVPT) vs Cellebrite DI (CLBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
AvePoint (AVPT) has outperformed Cellebrite DI (CLBT) over the past year, losing 3.5% versus a loss of 39.3%. Over five years, AVPT leads with a +69.8% price change compared with +8.2% for CLBT. AvePoint is the larger company by market cap ($2.99 billion vs $2.82 billion), about 1.1 times the size.
On valuation, Cellebrite DI trades at a lower forward P/E (17.1x vs 28.4x for AvePoint). Cellebrite DI converts more of its revenue into profit, with a net margin of 16.5% versus 8.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVPT | CLBT |
|---|---|---|
| Share price | $14.15 | $11.20 |
| Market cap | $2.99B | $2.82B |
| 1-day change | -0.91% | -0.21% |
| YTD return | +2.81% | -37.74% |
| 1-year return | -3.51% | -39.29% |
| 5-year return | +69.80% | +8.24% |
| P/E ratio (TTM) | 44.22 | 48.70 |
| Forward P/E | 28.44 | 17.15 |
| EPS (TTM) | $0.32 | $0.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $419.50M | $475.68M |
| Revenue growth (YoY) | +26.93% | +18.56% |
| Net income (latest FY) | $34.80M | $78.33M |
| Gross margin | 74.06% | 84.20% |
| Operating margin | 7.87% | 13.98% |
| Net margin | 8.30% | 16.47% |
| 52-week high | $15.48 | $19.98 |
| 52-week low | $8.84 | $9.58 |
| Distance from 52-week high | -8.59% | -43.94% |
| Analyst consensus | buy | none |
| Avg. price target upside | +18.80% | +37.12% |
| Average volume | 2.08M | 2.96M |
| Shares outstanding | 211.57M | 251.34M |
| Employees | 3,443 | 1,285 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AVPT has outperformed CLBT by 35.8 percentage points over the past year.
- Cellebrite DI is more profitable, keeping 16.5 cents of every revenue dollar as net income versus 8.3 cents for AvePoint.
- AvePoint grew revenue faster in its latest fiscal year (+26.93% vs +18.56%).
About AvePoint
AVPT stock →AvePoint, Inc. provides cloud-native data management software platform in North America, Europe, the Middle East, Africa, and the Asia Pacific.
Technology · Computer Software: Prepackaged Software · 3,443 employees
About Cellebrite DI
CLBT stock →Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Technology · Computer Software: Prepackaged Software · 1,285 employees
AVPT vs CLBT FAQ
Which is bigger, AvePoint or Cellebrite DI?
AvePoint (AVPT) is larger, with a market capitalization of $2.99B compared with $2.82B for Cellebrite DI (CLBT).
Which stock has performed better over the past year, AVPT or CLBT?
AVPT returned -3.51% over the past 12 months, compared with -39.29% for CLBT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, AVPT or CLBT?
AVPT has the lower trailing P/E at 44.2, versus 48.7 for CLBT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are AvePoint and Cellebrite DI in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.